A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease-Reference-Cited by-同舟云学术

A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease

Published:2014-01-16 Issue:6 Volume:61 Page:1068-1073
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Creary Susan E.¹,Gladwin Mark T.²,Byrne Melissa³,Hildesheim Mariana⁴,Krishnamurti Lakshmanan⁵

Affiliation:

1. Division of Pediatric Hematology-Oncology; Nationwide Children's Hospital; Columbus Ohio

2. Division of Pulmonary, Allergy, Critical Care Medicine, Vascular Medicine Institute; University of Pittsburgh; Pittsburgh Pennsylvania

3. Division of Pediatric Hematology-Oncology; Children's Hospital of Pittsburgh of UPMC; Pittsburgh Pennsylvania

4. Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine; University of Pittsburgh; Pittsburgh Pennsylvania

5. Division of Hematology/Oncology; Children's Hospital of Pittsburgh of UPMC; Pittsburgh Pennsylvania

Funder

Health Resources and Services Administration (HRSA)

Hemostasis and Vascular Medicine Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24931/fullpdf

Reference28 articles.

1. National Heart, Lung, and Blood Institute, Disease and Conditions Index: Sickle cell anemia: Who is at risk http://www.nhlbi.nih.gov/health/health-topics/topics/sca/atrisk.html

2. Mortality in sickle cell disease: Life expectancy and risk factors for early death;Platt;N Eng J Med,1994

3. Therapy preference and decision-making among patients with severe sickle cell anemia and their families;Hankins;Pediatr Blood Cancer,2007

4. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase;Cokic;J Clin Invest,2003

5. Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study;Hankins;Blood,2005

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxyurea mobile directly observed therapy versus standard monitoring in patients with sickle cell anemia: a phase 2 randomized trial;Communications Medicine;2024-08-09

2. Exploring health-related quality of life, exercise and alcohol use in adolescents with sickle cell disease and healthy siblings;Psychology & Health;2024-06-26

3. Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease;PLOS ONE;2024-06-25

4. Video-based direct observation physiotherapy in children with cystic fibrosis: a randomised controlled trial;European Respiratory Journal;2024-05-29

5. Adherence and Self-management;Care of Adults with Chronic Childhood Conditions;2024